Unpacking China | Key Chinese Firms to Watch This Week (15/11/2026-21/11/2026)

Technology, Mobility Author: EqualOcean News Updated 9 hours ago (GMT+8)

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

news

Weekly Overview(15/11-21/11)

1.BYD’s €4 Billion Szeged Plant in Hungary Set to Begin Mass Production

2.Johnson & Johnson to Acquire Ollin for Up to $3.3 Billion, With an Innovent-Licensed Drug Candidate at the Center of the Deal

3.MegaRobo Raises Nearly $200 Million With Backing From Oman Investment Authority

4.Xingyun Technology Signs Cross-Border AI Token Deal With RMB 2 Billion Initial Order and RMB 2 Billion?

5.Momenta Secures Nationwide Level 4 Testing Permit in Germany, Launches Robotaxi Pilot With Uber in Munich

6.Lenovo’s AI Server Order Backlog Reaches RMB 530 Billion as Q2 Revenue Rises 48%

7.Yuen Kee Food Group Clears Hong Kong Listing Hearing as Overseas GMV Rises 97% Year on Year

8.Alibaba Launches Qwen4-Max, Cutting Per-Task Costs by 60% From the Previous Generation

9.Victory Giant Technology Plans to Inject Up to $170 Million Into Its Malaysian Subsidiary

10.U.S. BIS Extends AI Chip Controls to Remote Computing Access, With Licensing Requirements for Five Countries

11.XPeng Expects Annual Overseas Sales to Top 100,000 for the First Time, After October Sales Rise 166% Year on Year

12.Goldwind’s Italian Subsidiary Signs Wind Turbine Supply and Installation Deal Backed by RMB 380 Million Guarantee

13.China Merchants Energy Shipping Takes Delivery of First Vessel for Qatar LNG Project Under Long-Term Shipping Agreement

14.Geely and Renault Strike Argentina Partnership, Tapping Renault’s Existing Dealer Network

15.Cainiao Partners With Vietnam Post to Deploy AI-Powered Logistics Systems

16.Link Touch Raises Several Hundred Million Yuan in Series D3, Bringing Six-Month Funding to Over RMB 1 Billion

Selected Development

1. BYD’s €4 Billion Plant in Szeged, Hungary, Set to Begin Mass Production

【Event】On November 15, BYD Executive Vice President He Zhiqi said the company’s plant in Szeged, Hungary, would soon enter mass production. The facility is BYD’s first passenger car plant in Europe. According to media reports, the project represents a total investment of about €4 billion and is designed to handle stamping, welding, painting and final assembly. He did not give a specific date for the start of mass production.

BYD previously confirmed that the first model built at the plant would be the DOLPHIN SURF, a compact electric car for the European market. The company has also signed a sheet steel supply agreement with Austrian steelmaker voestalpine, which will supply the Szeged plant from its facility in Linz.

Building cars within the EU could shorten delivery lead times for some BYD models and create opportunities for European suppliers. As the plant approaches mass production, the next milestones are deliveries of the DOLPHIN SURF, the pace at which the plant ramps up output and the share of components BYD can source in Europe.

2. Johnson & Johnson to Acquire Ollin for $2.2 Billion Upfront, With Innovent’s Eye Drug Candidate at the Center of the Deal

【Event】On November 16, Johnson & Johnson announced an agreement to acquire Ollin Biosciences, a U.S. biotech company focused on eye diseases. The deal includes an upfront payment of $2.2 billion and up to approximately $1.125 billion in additional regulatory and commercial milestone payments. Johnson & Johnson expects the transaction to close by the end of 2026, subject to applicable regulatory approvals and customary closing conditions.

Ollin’s lead drug candidate, OLN324, was developed by Innovent Biologics under the name IBI324 and licensed to Ollin. The candidate is being developed for wet age-related macular degeneration and diabetic macular edema. According to Innovent, Ollin has begun enrolling patients in global Phase 3 trials for both indications.

The deal illustrates how Chinese drugmakers can advance drug candidates internationally through licensing. Innovent first licensed the candidate to an eye disease specialist. If the acquisition closes, Johnson & Johnson will take over further development and can draw on its global commercial network to bring the drug to market if approved.

Under the original licensing agreement, Innovent received an upfront payment and an equity stake in Ollin. It is also eligible for milestone payments and tiered sales royalties. The acquisition announcement did not specify how much Innovent stands to receive. Its potential proceeds will depend on the value of its stake at closing and whether the drug meets the milestones in the licensing agreement.

3. MegaRobo Raises Nearly $200 Million With Backing From Oman Investment Authority

【Event】On November 19, MegaRobo announced that it had raised nearly $200 million in a new funding round. Oman Investment Authority, Oman’s sovereign wealth fund, and CMB International joined the round, while existing investors Asia Investment Capital, Granite Asia and Sinovation Ventures provided additional funding. MegaRobo will use the proceeds to develop its core technology and expand its AI for Science business internationally.

MegaRobo integrates AI software, scientific instruments and robotics into automated lab workflows for pharmaceutical companies, biotech firms and research institutions. The company says it has delivered products and technology to more than 500 customers, and its lab automation platform, Megalaxy Lab, has served more than 200.

Expanding a lab automation business overseas involves installing and maintaining equipment and integrating it into customers’ existing R&D workflows. MegaRobo’s experience with deployments gives it a base to build on. The pace of expansion will depend in part on how readily it can replicate those deployments across markets.

The Oman Investment Authority investment brings Middle Eastern capital into the company. MegaRobo did not announce any specific projects in Oman. The next developments to watch are whether the funding helps it win new international customers and how it delivers lab and technical services in its target markets.

4. Xingyun Technology Signs Cross-Border AI Token Deal With RMB 200 Million Initial Order

【Event】On the evening of November 18, Xingyun Technology announced that it had signed a 60-month cross-border AI token services agreement with New Silkroad Holding Group, along with an initial purchase order. Total billings under the agreement are capped at RMB 2 billion, and the initial order is valued at RMB 200 million. Both figures are tax-inclusive. The initial order covers Japan, South Korea, North America and Southeast Asia and includes AI inference services for text, images and video.

Xingyun will deliver the services through an application programming interface (API) and bill monthly based on actual token usage. The company identified digital content generation, food R&D and cross-border trade as potential uses. The model allows Xingyun to serve several markets on a pay-as-you-go basis, with business volume tied to ongoing customer usage.

Under the agreement, the first batch of service nodes must be ready by June 30, 2027, and billing begins only once service activation is confirmed. The RMB 2 billion figure is the five-year billing cap. Purchases beyond the initial order require separate orders. The deal’s contribution will depend on whether Xingyun can deliver on time and on subsequent usage, follow-on orders and gross margins.

5. Momenta and Uber Launch Robotaxi Pilot in Munich

【Event】On November 18, Momenta and Uber announced the launch of a robotaxi pilot in Munich, Germany. The pilot initially covers parts of northern Munich, including the area around Olympic Park. Users can register through the Uber app, with access opening in phases. Rides are free, and a trained safety operator is on board for each trip.

Momenta previously disclosed that it obtained a nationwide Level 4 autonomous driving test permit from Germany’s Federal Motor Transport Authority (KBA) in July. The pilot operates under the test permit, with passengers picked up and dropped off at designated stops within the Munich trial area.

Integration with Uber lets Momenta test the service within a booking process local riders already use. In addition to assessing how the vehicles perform on public roads, the companies can gauge whether passengers choose robotaxis and how well designated pickup and drop-off points work with Uber’s dispatch system.

The pilot is operating on a free, non-commercial basis under the terms of the permit. Any expansion of the service area or fleet, and any eventual move to regular paid service, will depend on pilot results and regulatory developments.


Contact Us:

Xingyiran@iyiou.com

yiran.png.png